Zydus Cadila acquires Nippon Universal Pharmaceutical

Zydus Cadila acquires Nippon Universal Pharmaceutical

Cadila Healthcare has announced that they are acquiring Tokyo based Nippon Universal Pharmaceutical. The financial aspects of this deal have not been revealed to the media.

The deal would help Cadila Healthcare gain an entry into the Japanese generics space. They are acquiring 100 per cent stake in the privately-held company.

Interestingly, they have already established a unit named Zydus Pharma Inc in Japan as they aim to capture a part of the 3 billion-dollar generics market.

Cadila Healthcare said in a statement: “The acquisition will provide critical access to a ready manufacturing and marketing base as well as a strong distribution reach. Nippon reaches out countrywide to more than 4,000 hospitals and clinics. This is expected to provide a fillip to the group’s operations in a market that is highly complex and dominated by local pharma companies.”